Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-24

Clinical Trial Update: A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating clevidipine butyrate injectable emulsion for hypertensive emergency; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clevidipine butyrate injectable emulsion (clevidipine butyrate)

Snippet

Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Conditions: Hypertensive Emergency | Phase 3 | Status: UNKNOWN